ABSTRACT BACKGROUND: Subacromial impingement syndrome is a common cause of pain in the shoulder region. When analgesics and physiotherapy are not helpful in relieving the patient's shoulder pain, subacromial methylprednisolone injection is given. The aim of this prospective study was to determine the one year clinical outcome of subacromial injections of methylprednisolone and physiotherapy in patients with subacromial impingement syndrome.
INTRODUCTION
Subacromial impingement syndrome is a common cause of pain in the shoulder region 1 . Various intrinsic (intratendinous) or extrinsic (extratendinous) factors can be responsible for the syndrome 2 . Rotator cuff muscle weakness, overuse and degeneration of the tendons are among the intrinsic causes while some of the extrinsic causes include the shape of the acromian process, degeneration of the AC joint, impingement by CA ligament, os acromiale and coracoid process. Sometimes in the younger individual, glenohumeral instability may be a secondary cause of sub-acromial impingement syndrome. When analgesics and physiotherapy are not helpful in relieving the patient's shoulder pain, subacromial corticosteroid injection is given 3 . The aim of this prospective study was to determine the one year clinical outcome of subacromial injections of methylprednisolone and physiotherapy in patients with subacromial impingement syndrome.
MATERIALS AND METHODS
Twenty nine patients with thirty painful shoulders characteristic of subacromial impingement syndrome seen by the two authors in four clinics from January 2007 to April 2009 were included in the study if they met the following criteria: 1.A diagnosis of subacromial impingement syndrome was made on the basis of history, clinical examination 4 and if a positive impingement sign was demonstrated as described by Hawkins and Kennedy 5 . The patients presented with pain on anterolateral aspect of shoulder which was referred to the deltoid insertion. On clinical examination, Jobe's test and Speed's test were positive along with decrease in active and passive range of motion of the shoulder. Any attempt to move the shoulder joint beyond this range was painful. 2.Pain did not subside with a week of NSAIDS ( Naproxen or Diclofenac sodium) .
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One year outcome of Subacromial Methylprednisolone
Injection and Psychotherapy for Subacromial Impingement Syndrome Plain x-rays of the shoulder AP, lateral and axillary views were taken. Features suggestive of glenohumeral instability, degenerative joint disease , cervical radiculitis, calciÞ c tendinitis, adhesive capsulitis, isolated AC joint arthritis 2 , unfused acromial epiphysis 6 and suprascapular nerve compression were excluded from the study. Similarly, patients with clinical and routine x-ray pictures of massive rotator cuff tears 7 were excluded from the study as were patients < 40 years of age as they could have subtle glenohumeral instability 8 contributing to subacromial impingement syndrome.
The shoulder pain was assessed by Visual Analogue Scale (VAS) scores of 0 to 10, and overall clinical and function of the involved shoulder were assessed by Constant Murley Score 9 . Each shoulder received 4ml of plain 1% xylocaine mixed with 2ml of methyl prednisolone (containing 80 mg ) injections. A 10 cc syringe with 5 cm long, 21 g needle was used to instill the injection in the sub-acromial space by the posterior approach. Inj. Diclofenac 75 mg was given IM in the gluteal region followed by oral analgesics (codeine 10 mg. and paracetamol 500 mg. combination tablets) three times a day for three days. The subacromial injections were repeated at two to three weekly intervals (a maximum of three injections) until the pain subsided to 2 or less in the VAS. This was followed by physiotherapy exercises. In one patient, it did not go below 5 even after 3 injections. She was advised surgery, but she opted for physiotherapy exercises and oral analgesics.
Rehabilitaion was undertaken in 3 basic phases as deÞ ned by Wirth et al. 10 1. Pain was controlled 2. Range of motion of the shoulder joint was restored 3. Rotator cuff muscle strengthening was developed.
Treatment Outcome at Þ nal follow-up of one year was measured using VAS and Constant Murley 9 score.
Constant and Murley score 9 provides an overall clinical and functional assessment of the shoulder irrespective of the diagnostic or radiological abnormalities caused by disease or injury. It is accurately reproducible by different observers and sufÞ ciently sensitive to reveal even small changes in function. It is a100 point scoring system based on a number of individual parameters. (Table-1 The subjective parameters, which comprise of 35 points, assess the degree of pain the patient experiences and the ability to perform normal tasks of activities of daily living. The objective parameters, which comprise of 65 points, assess active range of motion of the shoulder that allows placement of upper limb in functionally relevant position and the power in the shoulder joint.
Data entry was done in Microsoft Excel 2007 version and analysis was done using SPSS version 16 programme. Paired t-test was applied to assess the statistical signiÞ cance of pain and shoulder function before and after treatment.
RESULTS
Twenty nine patients with thirty shoulders (15 men and 14 women) with a mean age of 54.7 years (range 42 to 72 years; std. deviation: 8.699) who met the criteria were included in the study. The mean duration of symptoms before the injection was 2.07 months (range 1 to 6 months; std. deviation: 1.172). The right shoulder was involved in 18 patients and left shoulder in 12 patients. The shoulder pain was of spontaneous onset in 21 patients whereas in 8 patients, they attributed it to an incident of strain/ minor injury.
The patients were followed up for a minimum of one year. Pain before starting the injections was a mean of 7.87 in the VAS (range: 5-10 ). At the end of follow-up, it was a mean of 1.27 (range: 0 to 5 The objective of treatment is reduction of pain and improvement of shoulder function. When NSAIDs and physiotherapy are unable to control the pain, subacromial steroid injection is given. Subacromial injections can be given by anterior, posterior or lateral approach. Among the steroid injections, depot formulations are chosen for subacromial injections. Depot formulation tend to remain at the injection site for a long period of time and display mainly local effects as compared to watersoluble formulations like Dexamethasone which diffuse rapidly from the injected site and exert mainly systemic effects 16 . The choice of depot formulation depends on a variety of factors including availability, cost and pharamacokinetics of the agent 16 . Methylprednisolone and Triamcinolone are the depot formulation commonly available in the market .The reported ranges for duration of action vary between different corticosteroids and sometimes, for the same corticosterod. Accuracy of needle placement can affect the outcome of soft tissue disorders. Only 30 to 80 percent of subacromial injections are reported to reach the subacromial bursa or space when a blind injection technique is used 17 . Use of sonography could increase the accuracy of injection and thereby improve outcome 18 . By using 2 to 3 weekly subacromial methylprednisolone injections up to a maximum of 3 injections, we believe, the inaccuracy of blind subacromial injections was taken care of.
Outcome periods of local steroid injections are categorised as short term ( 6 weeks ), intermediate term ( 6 weeks to 6 months ) and long term ( more than 6 months ) 16 . This study is a one year follow up study of treatment of subacromial methylprednisolone injection and physiotherapy for subacromial impingement syndrome, and therefore, can be termed as long term study.
28 patients with 29 shoulders were satisÞ ed with the level of pain control and improvement of shoulder function achieved by subacromial methylprednisolone injections followed by physiotherapy exercises. One patient did not achieve satisfactory pain control ( VAS of 5 after 3 injections) with the three subacromial methylprednisolone injections and was advised surgery. She didn't want surgery and opted for physiotherapy exercises. The pain did not decrease at the end of one year. However at the end of eighteen months follow up, she had no pain and could carry out all her activities of daily living without any difÞ culties. A patient with bilateral subacromial impingement syndrome, who was doing well at end of one year follow up with good pain control and shoulder function, had recurrence of pain at eighteen months follow up. Two repeat subacromial methylprednisolone injections for each shoulder did not help relieve her pain and she was advised surgery. The patient satisfaction rate of subacromial methylprednisolone injection for subacromial impingement syndrome at the end of one year (long term outcome) was 96.7% (29 of 30 shoulders). However, at eighteen months follow-up, it was 93.3% (28 of 30 shoulders).
Literature search revealed satisfactory results with conservative treatment including NSAIDs and physiotherapy exercises are 67% in one study 19 . In a recent study based on conservative programme including NSAIDs, physiotherapy and subacromial steroid injections, an overall success rate of 70% was obtained in treating patients with subacromial impingement syndrome 20 . There were certain limitations in our study: there were only 30 shoulders included in the study and it involved an only one year follow up period.
CONCLUSION
Subacromial methylprednisolone injections given by trained orthopaedic surgeons followed by physiotherapy exercises can provide statistically and clinically satisfactory pain relief and improvement of shoulder function in a one year follow up of 96.7% patients with subacromial impingement syndrome. However, a study involving more patients followed up for longer term periods could more accurately conclude the long term outcome of subacromial methylprednisolone injections in these patients.
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